Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Revolution Medicines (RVMD) Gross Profit: 2019-2025

Historic Gross Profit for Revolution Medicines (RVMD) over the last 5 years, with Sep 2025 value amounting to -$11.4 million.

  • Revolution Medicines' Gross Profit was N/A to -$11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.7 million, marking a year-over-year change of. This contributed to the annual value of -$2.5 million for FY2024, which is 121.83% down from last year.
  • Latest data reveals that Revolution Medicines reported Gross Profit of -$11.4 million as of Q3 2025, which was down 506.84% from $2.8 million recorded in Q4 2024.
  • Revolution Medicines' Gross Profit's 5-year high stood at $15.3 million during Q4 2022, with a 5-year trough of -$11.4 million in Q3 2025.
  • In the last 3 years, Revolution Medicines' Gross Profit had a median value of $1.8 million in 2023 and averaged $25,333.
  • Over the last 5 years, Revolution Medicines' Gross Profit had its largest YoY gain of 278.57% in 2024, and its largest YoY loss of 140.05% in 2024.
  • Revolution Medicines' Gross Profit (Quarterly) stood at $9.5 million in 2021, then skyrocketed by 62.05% to $15.3 million in 2022, then plummeted by 95.16% to $742,000 in 2023, then spiked by 278.57% to $2.8 million in 2024, then reached -$11.4 million in 2025.
  • Its Gross Profit was -$11.4 million in Q3 2025, compared to $2.8 million in Q4 2024 and -$2.8 million in Q1 2024.